Amgen gets FDA approval for osteoporosis drug Evenity
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen, Novartis sue each other over migraine drug Aimovig
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Cure Pharmaceutical acquiring Chemistry Holdings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Gold Coast Health investing in community
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Letter to the editor: Keep the promise of the Lanterman Act alive
Dear Editor: California is at a crossroads. the Lanterman Act was groundbreaking legislation passed in 1969 that guaranteed the rights of people with developmental disabilities, including services and support in natural community settings, to the greatest extent possible. The state system created under the Lanterman Act, relied upon by 330,000 Californians with intellectual and/or developmental Read More →
Read More →